-
Electronic (PDF)
-
Site License
-
Enterprisewide
Enzon Pharmaceuticals, Inc.: Company Profile and SWOT Analysis
iCD Research, December 2011, Pages: 36
Synopsis
ICD Research's "Enzon Pharmaceuticals, Inc.: Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, business description, financial ratios, SWOT analysis, key facts, information on products and services, details of locations and subsidiaries, plus information on key news events affecting the company.
Summary
This SWOT analysis and company profile is a crucial resource for industry executives and anyone looking to gain a better understanding of the company's business.
ICD Research's "Enzon Pharmaceuticals, Inc.: Company Profile and SWOT Analysis" report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.
Scope
- Examines and identifies key information and issues about "Enzon Pharmaceuticals, Inc." for business intelligence requirements
- Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported
- Provides analysis on financial ratios of the company along with a competitor benchmarking section
- The profile also contains information on business operations, company history, major products and services, prospects, key competitors, key employees, locations and subsidiaries
Reasons To Buy
- Quickly enhance your understanding of the company
- Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry
- Increase business/sales activities by understanding your competitors’ businesses better
- Recognize potential partnerships and suppliers
- Obtain yearly profitability figures
Key Highlights
Enzon Pharmaceuticals, Inc. (Enzon) is a biopharmaceutical company that specializes in the development, manufacture and commercialization of pharmaceutical products for cancer. The company has four compounds in clinical development, PEG-SN38, HIF-1 alpha mRNA antagonist, Survivin mRNA antagonist and Androzen receptor mRNA antagonist. It uses its proprietary technologies including Customized Linker Technology, PEGylation and the Locked Nucleic Acid (LNA) for the development of its drugs. The company operates in the US and Europe. Enzon is headquartered in Bridgewater, New Jersey, the US.
1 Business Analysis
1.1 Company Overview
1.2 Business Description
1.3 Major Products and Services
2 Analysis of Key Performance Indicators
2.1 Five Year Snapshot: Overview of Financial and Operational Performance Indicators
2.2 Key Financial Performance Indicators
2.2.1 Revenue and Operating Profit
2.2.2 Asset, Liabilities and Capex
2.2.3 Solvency
2.3 competitive benchmarking
2.3.1 Market Capitalization
2.3.2 Efficiency
2.3.3 Capital Expenditure
2.3.4 Turnover - Inventory and Asset
3 Mergers & Acquisitions and Partnerships
3.1 M&A and Partnerships Strategy
4 Recent Developments
5 SWOT Analysis
5.1 SWOT Analysis - Overview
5.2 Strengths
5.3 Weaknesses
5.4 Opportunities
5.5 Threats
6 Enzon Pharmaceuticals, Inc. - Company Statement
7 history
8 Enzon Pharmaceuticals, Inc. - Key employees
9 Key employee Biographies
10 locations and Subsidiaries
10.1 Head Office
10.2 Other locations and Subsidiaries
11 Appendix
11.1 Methodology
11.2 Ratio Definitions
11.3 Disclaimer
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW4
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
